IPO
DiaMedica Therapeutics Inc.
We are a clinical stage biopharmaceutical company primarily focused on the development of novel recombinant (synthetic) proteins. Our goal is to use our patented and licensed technologies to establish our company as a leader in the development and commercialization of novel recombinant proteins to treat neurological and kidney diseases.
Symbol
DMAC
Price Range
TBD
Anticipated Date
TBD
Underwriters
Craig-Hallum Capital Group
To view the prospectus for DiaMedica Therapeutics Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277